Jennifer Arnold, MD

Neurologist

Neurology

Accepting new patients

Call for an appointment

217-545-8000

I am a:

Request appointment

Language:

English

About me

Gender

Female

Education & training

Positions

Assistant Professor

Medical School

MD, University of Illinois

Doctorate Degree

Ph.D. Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign

Undergraduate Degree

BS Biology, Southeast Missouri State University

Residency

Neurology, University of Michigan

Fellowship

Neurodegenerative Diseases, University of Michigan

Specialties

Neurology

Conditions

Appointments

SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community.

Request an appointment

Clinical locations

Locations

SIU Medicine Neurology | Moy Building

751 N. Rutledge St. Springfield, IL 62702 Suite 3100

Get Directions

Mon - Fri: 8:00 am-4:30 pm

Hospital privileges

HSHS St. John's Hospital, Springfield, IL
Memorial Health, Springfield IL

Clinical trials

Trial

Neurology

A 6-month (stage 1) & 18-month (stage 2) prospective, randomized, placebo-controlled, doubleblind dual clinical trial investigating efficacy and safety of buntanetap in treating participants with early Alzheimer’s disease

Active recruiting

In this study, the safety and efficacy of buntanetap will be assessed in a diverse population of early AD participants via a randomized, double-blind, placebo-controlled, multicenter Phase 3 trial.

Trial

Neurology

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild to Moderate Alzheimer’s Disease (MINDSET 2)

Active recruiting

The purpose of this research is to learn if the experimental study drug KarXT + KarX-EC works to treat thinking and memory problems as well as improve overall function in people with Alzheimer’s disease (AD).

Trial

Neurology

ADCS Benfo: A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients with Early Alzheimer’s Disease (BenfoTeam)

Active recruiting

The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine, to determine whether it delays or slows the progression of the symptoms of early Alzheimer’s disease.

Trial

Neurology

Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

Active recruiting

ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.